United States · Investor

Boxer Capital

Last cheque observed Oct 2025. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

SeedSeries ASeries BBiotechnologyPrecision Medicine

Cheques on record
0%of best year0cheques in 12 months, 17 on record
Since the last cheque390days00hrs00min00sec
Median round$80MCheque size, as they say$100K – $5.0MRounds led1 of 17Sole investor1 roundsMostly inUnited States, 88%
Pitch Boxer Capital

Boxer Capital highlights

  1. 01

    17 rounds on record

  2. 02

    Mostly Series C and Series B: 69% of its rounds

  3. 03

    Sole investor in 1 rounds, median $40M

What they do

Boxer Capital Management is a full life cycle investment firm, committed to fundamental, research-based investing in specialized and precision medicine companies across private and public markets.From their own website
Type
VC firm (from a list, unverified)
Cheque size
$100K – $5.0M as they say
Stages
SeedSeries ASeries BGrowth
Sectors
BiotechnologyPrecision Medicine
Based in
Windermere, United States
Cold pitches
Not accepted

The record

Every round we can evidence, newest first17 appearances

  1. 2025

    1 round

  2. Oct
    Zag BioSeries A · US · Firms' own news pages$80MWith 9 others
  3. 2019

    8 rounds

  4. Dec
    Black Diamon TherapeuticsSeries C · US · FinSMEs$85MLed
  5. Nov
    PMV PharmaSeries C · US · Prweb$62MWith 7 others
  6. Jul
    Revolution MedicinesSeries C · US · FinSMEs$100MWith 9 others
  7. Apr
    Poseida TherapeuticsSeries C · US · FinSMEs$142MWith 7 others
  8. Apr
    SpringWorks TherapeuticsSeries B · US · FinSMEs$125MWith 12 others
  9. Mar
    Prevail TherapeuticsSeries B · US · Medcitynews$50MWith 10 others
  10. Jan
    Attune PharmaceuticalsSeries B · US · Globenewswire$23MWith 5 others
  11. Jan
    SojournixSeries C · US · FinSMEs$44MWith 5 others
  12. 2018

    5 rounds

  13. Dec
    Akero TherapeuticsSeries B · US · FinSMEs$70MWith 9 others
  14. Oct
    Milestone PharmaceuticalsCA · FinSMEs$80MWith 9 others
  15. Sept
    AtrecaSeries C · US · FinSMEs$125MWith 7 others
  16. Mar
    IdeayaSeries B · US · FinSMEs$94MWith 12 others
  17. Mar
    PrevailSeries A · FinSMEs$75MWith 8 others
  18. 2017

    1 round

  19. Jan
    CiVi BiopharmaSeries A · US · FinSMEs$40MSole investor
  20. 2015

    2 rounds

  21. Sept
    AveXisSeries D · US$65MWith 11 others
  22. Aug
    Telesta TherapeuticsVenture · CA$29MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration5 named

AIAaron Isaac DavisChief Executive OfficeriForm ADV
ARAndrew Ruel EllisChief Legal OfficeriForm ADV
CFChristopher FuglesangSenior Managing DirectoriForm ADV
MBMichael BeauchampVp of FinanceiForm ADV
NTNatalie Theresa RobertsChief Compliance OfficeriForm ADV

We also hold 12 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$578Massets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
Legal name
Boxer Capital Management, LLC
SEC number
CRD 330106

Funds on its Form ADV

1 private fund, $2.5B in gross assets · filed Nov 2024

  1. Boxer Capital, LLCHedge6 investors$2.5B

Who they invest alongside

The investors most often in the same rounds as Boxer Capital. A count of rooms they were both in, not a relationship either has claimed.

BVF PartnersVC firm6rounds togetherOrbiMedPrivate equity4rounds togetherRA Capital ManagementPrivate equity4rounds togetherAlexandria Real Estate EquitiesVC firm3rounds togetherCormorant CapitalVC firm3rounds togetherDeerfieldVC firm3rounds togetherEcoR1 CapitalPrivate equity3rounds togetherOmega FundsVC firm3rounds togetherVenrockVC firm3rounds togetherAbbVieCorporate VC2rounds togetherAdage Capital ManagementAsset manager2rounds togetherCasdin CapitalVC firm2rounds together

Recently backed

The latest companies Boxer Capital put money into.

Zag Bio$80M · Oct 2025Revolution Medicines$100M · Jul 2019SpringWorks Therapeutics$125M · Apr 2019Akero Therapeutics$70M · Dec 2018Milestone Pharmaceuticals$80M · Oct 2018CiVi Biopharma$40M · Jan 2017

Quick answers about Boxer Capital

What does Boxer Capital invest in?

Boxer Capital invests most often at Series C and Series B (69% of the rounds on record), in sectors such as Biotechnology and Precision Medicine.

How active is Boxer Capital?

17 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Oct 2025.

What has Boxer Capital invested in recently?

Its most recent investments on record: Zag Bio (Series A, Oct 2025), Black Diamon Therapeutics (Series C, Dec 2019) and PMV Pharma (Series C, Nov 2019).

How big are Boxer Capital's cheques?

The median round it joins is $80M. It says it writes cheques of $100K to $5.0M.

Does Boxer Capital lead rounds?

Sometimes: it led 1 of its 17 investments on record (6%).

Where does Boxer Capital invest?

Most of the companies it backs are in the United States (88%) and Canada (13%).

Is Boxer Capital investing now?

No investments in the last 12 months; the latest was in Oct 2025.

Who does Boxer Capital invest alongside?

Most often BVF Partners (6 rounds together), OrbiMed (4 rounds together) and RA Capital Management (4 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it